Revolution Medicines, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Revolution Medicines, Inc. reported Cash And Cash Equivalents At Carrying Value of $383.75 million for the year ending 2025.

  • Revolution Medicines, Inc. showed a decrease of -29.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Revolution Medicines, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Revolution Medicines, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 451.5%.
  • Historical annual values: Fiscal year 2025: $383.75 million | Fiscal year 2024: $543.06 million | Fiscal year 2023: $696.15 million | Fiscal year 2022: $161.41 million | Fiscal year 2021: $108.50 million | Fiscal year 2020: $104.27 million | Fiscal year 2019: $16.66 million | Fiscal year 2018: $69.59 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: